Response to ASX Price Query

Key points

• No undisclosed information that could explain recent trading
• Company complying with Listing Rules and continuous disclosure policy
• Carrying on business in ordinary course as per disclosed strategy

Full summary

Cyclopharm Ltd has responded to an ASX price query regarding the recent increase in the price and trading volume of its securities. The company has confirmed that it is not aware of any information concerning it that has not been announced to the market and which could explain the recent trading. Cyclopharm stated that it is carrying on business in the ordinary course in accordance with its disclosed strategic direction and commercialisation plan, and that it is complying with the ASX Listing Rules, particularly Listing Rule 3.1. The company also confirmed that its responses to the ASX's queries have been authorised and approved under its published continuous disclosure policy.